Manufacturing

#Covid-19 #Diagnostics #Manufacturing

GADx launches as social enterprise for diagnostics  

Diagnostics company Mologic and its sister company Global Access Diagnostics (GAD) have combined their expertise to form a new business aimed at addressing the gaps in the provision of diagnostics, with a focus on expanding affordable access to quality tests.  Global Access Diagnostics (GADx) is the first… Read More

#News

#CDMO #Manufacturing

Ten23 announces Swiss manufacturing expansion  

Global contract development and manufacturing organisation (CDMO) ten23 health has announced an expansion to its facility in Switzerland.  The company is expanding swissfillon’s manufacturing site, a sterile filling supplier who joined ten23 in 2021.   Ten23 will expand the site with a new manufacturing… Read More

#News

#CDMO #Manufacturing

Bachem & Eli Lilly partner on oligonucleotide project  

Swiss pharmaceutical company Bachem has partnered with Eli Lilly on a seven-year agreement to advance the development of oligonucleotide-based drug substances.   The agreement will see the two companies contribute to global manufacturing capacity for oligonucleotide-based medicines for patients.  Through the collaboration Bachem will… Read More

#News

#Clinical development #Clinical trials #Manufacturing

SMC opens new pharma business in Cambridge  

Solutions provider SMC Ltd has opened a new business offering pharmaceutical development services at the Cambridge Research Park in the UK.  Cambridge Pharma offers pharmaceutical development services, including sterile fill-finish and launches with a 20,000 sq. ft facility offering a range of manufacturing services for clinical trial… Read More

#News

Sustainability concept
#Manufacturing #Sustainability

ten23 achieves multiple sustainability milestones   

Global contract development and manufacturing organisation (CDMO) ten23 has made progress in its sustainability goals, the company has announced.   The CDMO has announced it has become a “Pending B Corporation”, meaning that it meets the legal accountability requirement for B Corp Certification and takes measures to manage… Read More

#News

#Biologics / Biotechnology #Clinical trials #Manufacturing #Pharma

This week in drug discovery (2-6 May)   

Swiss biotech sector sees strong performance in 2021, report says  Switzerland’s life sciences sector saw a strong year in 2021 with companies contributing to the Covid-19 pandemic and high levels of capital investments being key indicators of the sector’s strength.   This is according to the… Read More

#News

#Biopharma #Cell and gene therapy #Manufacturing #Project Farma

Cell and gene therapies: Opportunities for innovation

By Dr. Deborah Phippard, Chief Scientific Officer of Precision for Medicine and Anshul Mangal, President & General Counsel, Project Farma. In recent years the advanced therapy industry has been the most significant disruptor in medicine. Cell and gene therapies are transforming the way diseases are treated but are also aiming to cure entirely new… Read More

#Business & Investment #Exclusive Content

#Covid-19 #GlobalData #Manufacturing

Opportunities linked to increase in FDA approvals of Covid-19 products  

An increasing number of approvals and Emergency Use Authorisations (EUAs) by the Food and Drug Administration (FDA) for Covid-19 vaccines and drugs, as well as cell and gene therapies, is helping provide manufacturing opportunities for contract manufacturing organisations (CMOs).  This is according to GlobalData’s latest report –… Read More

#News